Developing novel vaccines and therapeutic proteins | Medicago

- medicago.com

Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.

851,392 $ 1,440.00


Developing novel vaccines and therapeutic proteins | Medicago

- vlpexpress.com

Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.

Not Applicable $ 8.95